Budesonide Impurity C(CAS番号:1040085-99-1)

基本情報

Budesonide Impurity C

CAS番号

1040085-99-1

分子式

C25H34O6

分子量

430.54 g/mol

Quick Actions

基本的な物理特性

SMILES

CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C(=O)C2(O1)CO)C)O)C

InChI

InChI=1S/C25H34O6/c1-4-5-20-30-19-11-17-16-7-6-14-10-15(27)8-9-23(14,2)21(16)18(28)12-24(17,3)22(29)25(19,13-26)31-20/h8-10,16-21,26,28H,4-7,11-13H2,1-3H3/t16-,17-,18-,19+,20?,21+,23-,24-,25+/m0/s1

InChIKey

DRLZLIQUOCVRLM-PINIVEOHSA-N

LogP

2.716800000000001

トポロジカル極性表面積

93.06 Ų

水素結合ドナー/アクセプター

2 / 6

複雑度

862

分類と用途

安全情報

安全情報を表示

同義語と参考文献

英語

  • 16α,17-[(1RS)-Butylidenebis(oxy)]-11β-hydroxy-17-(hydroxymethyl)-D-homoandrosta-1,4-diene-3,17a-dione (Mixture of Diastereomers)
  • 16α,17-[(1RS)-Butylidenebis(oxy)]-11β-hydroxy-17-(hydroxymethyl)-D-homoandrosta-1,4-diene-3,17a-dion
  • 16α,17-[(1RS)-Butylidenebis(oxy)]-11β-hydroxy-17-(hydroxymethyl)-D-homoandrosta-1,4-diene-3,17a-dione (Mixture of Diastereomers)
  • 16α,17-[(1RS)-Butylidenebis(oxy)]-11β-hydroxy-17-(hydroxymethyl)-D-homoandrosta-1,4-diene-3,17a-dione (Mixture of Diast...
  • Budesonide IMpurity C
  • Budesonide EP Impurity C
  • 16α,17-[(1RS)-butylidenebis(oxy)]-11β-hydroxy-17-(hydroxymethyl)-D-homoandrosta-1,4-diene-3,17a-dione
  • 16α,17-[(1RS)-Butylidenebis(oxy)]-11β-hydroxy-17-(hydroxymethyl)-D-homoandrosta-1,4-diene-3,17a-dione \n(Mixture of Diastereomers)
  • (4aR,4bS,5S,6aS,7aR,10aR,11aS,11bS)-4b,6,6a,7a,10a,11,11a,11b,12,13-Decahydro-5-hydroxy-7a-(hydroxymethyl)-4a,6a-dimethyl-9-propyl-chryseno[2,3-d][1,3]dioxole-2,7(4aH,5H)-dione
  • (4aR,4bS,5S,6aS,7aR,10aR,11aS,11bS)-5-hydroxy-7a-(hydroxymethyl)-4a,6a-dimethyl-9-propyl-4b,6,6a,7a,10a,11,11a,11b,12,13-decahydrochryseno[2,3-d][1,3]dioxole-2,7(4aH,5H)-dione
  • Budesonide Impurity C
  • Chryseno(2,3-d)(1,3)dioxole-2,7(4ah,5H)-dione, 4b,6,6a,7a,10a,11,11a,11b,12,13-decahydro-5-hydroxy-7a-(hydroxymethyl)-4a,6a-dimethyl-9-propyl-, (4aR,4bS,5S,6aS,7aR,10aR,11aS,11bS)-
  • Chryseno[2,3-d][1,3]dioxole-2,7(4aH,5H)-dione, 4b,6,6a,7a,10a,11,11a,11b,12,13-decahydro-5-hydroxy-7a-(hydroxymethyl)-4a,6a-dimethyl-9-propyl-, (4aR,4bS,5S,6aS,7aR,10aR,11aS,11bS)-; 16?,17-[(1RS)-Butylidenebis(oxy)]-11?-hydroxy-17-(hydroxymethyl)-D-homo-androsta-1,4-diene-3,17a-dione; Budesonide Imp. C (EP)
  • G14641
  • 16alpha,17-((1RS)-Butylidenebis(oxy))-11beta-hydroxy-17-(hydroxymethyl)-D-homoandrosta-1,4-diene-3,17a-dione
  • 16a,17-[(1RS)-Butylidenebis(oxy)]-11b-hydroxy-17-(hydroxymethyl)-D-homoandrosta-1,4-diene-3,17a-dione
  • 16a,17-[(1RS)-Butylidenebis(oxy)]-11b-hydroxy-17-(hydroxymethyl)-D-homoandrosta-1,4-diene-3,17a-dione (Mixture of Diastereomers)
  • 7BYQ3VT7JN
  • 16alpha,17-[(1RS)-Butylidenebis(oxy)]-11beta-hydroxy-17-(hydroxymethyl)-D-homoandrosta-1,4-diene-3,17a-dion
  • (4aR,4bS,5S,6aS,7aR,10aR,11aS,11bS)-5-hydroxy-7a-(hydroxymethyl)-4a,6a-dimethyl-9-propyl-5,6,10a,11,11a,11b,12,13-octahydro-4bH-chryseno[2,3-d][1,3]dioxole-2,7-dione
  • D-HOMOBUDESONIDE
  • 16?,17-[(1RS)-Butylidenebis(oxy)]-11?-hydroxy-17-(hydroxymethyl)-D-homo-androsta-1,4-diene-3,17a-dione
  • Budesonide impurity C [EP]
  • 16.ALPHA.,17-((1RS)-BUTYLIDENEBIS(OXY))-11.BETA.-HYDROXY-17-(HYDROXYMETHYL)-D-HOMOANDROSTA-1,4-DIENE-3,17A-DIONE
  • Chryseno[2,3-d][1,3]dioxole-2,7(4aH,5H)-dione, 4b,6,6a,7a,10a,11,11a,11b,12,13-decahydro-5-hydroxy-7a-(hydroxymethyl)-4a,6a-dimethyl-9-propyl-, (4aR,4bS,5S,6aS,7aR,10aR,11aS,11bS)-
  • UNII-7BYQ3VT7JN
  • BUDESONIDE IMPURITY C [EP IMPURITY]
  • 1040085-99-1

MDL_Number

MFCD29920082

CAS番号

1040085-99-1

サプライヤー情報

サプライヤー名 会員レベル 認証状況 主要カテゴリー 最小注文数量 アクション
中国中国 - Famous Biology & Technology Co., Ltd., Hubei Province
中国中国 - Hubei Yangxin Pharmaceutical Technology Co., Ltd.
中国中国 - Hubei De Ao Hua Yan Yiyao Technology Co., Ltd.
中国中国 - Shanghai Kewei Chemical Technology Co., Ltd.
中国中国 - Shijiazhuang Yaobo Medicine Technology Co., Ltd.
中国中国 - Shanghai Yuansi Biotechnology Co., Ltd.
中国中国 - Hubei Rieno Pharmaceutical Technology Co., Ltd.
中国中国 - Jiangmen Hengyi Real Industry Co., Ltd.

関連論文

Tessellation strategy for the interfacial synthesis of an anthracene-based 2D polymer via [4+4]-photocycloaddition

Renzeng Chen, Danbo Wang, Wenbo Hao, Feng Shao, Yingjie Zhao

2021-05-07 Communication

DOI: 10.1039/D1CC02179F

Transition metal chemistry in synthetically viable alkaline earth complexes M(Cp)3− (M = Ca, Sr, Ba)

Bin Huo, Rui Sun, Bo Jin, Lingfei Hu, Jian-Hong Bian, Xiao-Ling Guan, Caixia Yuan, Gang Lu, Yan-Bo Wu

2021-04-14 Communication

DOI: 10.1039/D1CC01753E

Life cycle assessment of power-to-gas with biogas as the carbon source

Xiaojin Zhang, Julia Witte, Tilman Schildhauer, Christian Bauer

2019-12-17 Paper

DOI: 10.1039/C9SE00986H

Carbon-based photocatalysts for enhanced photocatalytic reduction of CO2 to solar fuels

Mufeedah Muringa Kandy

2019-11-06 Review Article

DOI: 10.1039/C9SE00827F

Cu2ZnSnS4 nanocrystals for microwave thermal and microwave dynamic combination tumor therapy

Taya Tang, Xiaomu Xu, Zhiwen Wang, Jijing Tian, Yue Yang, Caizhang Ou, Huihui Bao, Tianlong Liu

2019-10-10 Communication

DOI: 10.1039/C9CC07762F

Catalogue of self-targeting nano-medical inventions to accelerate clinical trials

Samar A. Alsudir

2021-04-15 Review Article

DOI: 10.1039/D1BM00235J

In situ growth of all-inorganic perovskite nanocrystals on black phosphorus nanosheets

Hao Huang, Jia Li, Ya Yi, Jiahong Wang, Yihong Kang, Paul K. Chu, H. C. Ong, Xue-Feng Yu

2018-02-08 Communication

DOI: 10.1039/C8CC00029H

Mechanism of lignocellulose modification and enzyme disadsorption for complete biomass saccharification to maximize bioethanol yield in rapeseed stalks

Xiaobo Zhu, Shang-wen Tang, Wenyue Zhao, Xianliang Li, Zhengyi Lv, Li Yu

2019-11-28 Paper

DOI: 10.1039/C9SE00906J

Selective production of monocyclic aromatic hydrocarbons from ex situ catalytic fast pyrolysis of pine over the HZSM-5 catalyst with calcium formate as a hydrogen source

Kai Li, Ze-xiang Wang, Guan Zhang, Min-shu Cui, Qiang Lu, Yong-ping Yang

2019-10-28 Paper

DOI: 10.1039/C9SE00605B

Biomimetic hydrogels designed for cartilage tissue engineering

Alexander Stokes, Piergiorgio Gentile, Ana M. Ferreira

2021-02-12 Review Article

DOI: 10.1039/D0BM01852J